ROIV
Roivant Sciences Ltd. (ROIV)
$44
About Roivant Sciences Ltd. (ROIV)
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. Its product portfolio includes Vtama, Batoclimab, Brepocitinib, Namilumab, and RVT-2001, which aims to treat psoriasis, atopic dermatitis, thyroid eye disease, and other illnesses. The company was founded by Vivek Ramaswamy on April 7, 2014 and is headquartered in London, the United Kingdom.
Details
Daily high
$10.70
Daily low
$10.42
Price at open
$10.70
52 Week High
$13.06
52 Week Low
$9.96
Market cap
7.4B
Dividend yield
0.00%
Volume
5.7M
Avg. volume
7.1M
P/E ratio
-72.05
Roivant Sciences Ltd. News
Details
Daily high
$10.70
Daily low
$10.42
Price at open
$10.70
52 Week High
$13.06
52 Week Low
$9.96
Market cap
7.4B
Dividend yield
0.00%
Volume
5.7M
Avg. volume
7.1M
P/E ratio
-72.05